Brazil Pharma Industry to Witness Astounding Growth in Five Years
According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", Brazil has potential to become the third largest pharma markets after the US and China. Government's support to encourage domestic generics industry, patent expiries, increasing healthcare expenditure of public and private insurance sector, rising disposable income, rising ageing population etc., have been the major growth drivers. Brazil is the only Country in emerging world to have a subsequent increase in the healthcare expenditure which is one...
View full press release